Oral supplements in the treatment and prevention of joint diseases: A review of their potential application to the horse

Equine Veterinary Education

Volumn 13, Issue 3, 2001, Pages 135-139

  Wright, I M ^a  

^a Reynolds House Referrals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347039397     PISSN: 09577734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2001.tb00078.x     Document Type: Article

References (65)

1. Anderson, C.C., Cook, J.L., Kneeger, J.M., Tomlinson, J.L. and Wagner-Mann, C.C. (1999) In vitro effects of glucosamine and acetylsalicylate on canine chondrocytes in three-dimensional culture. Am. J. vet. Res. 60, 1546-1551.
2. Andermann, G. and Dietz, M. (1982) The influence of the route of administration on the bioavailability of an endogenous macromolecule: chondroitin sulphate (CSA). Eur. J. Drug Met. Pharmacol. 7, 11-16.
3. Avouac, B. (1993) Slow acting drugs in osteoarthritis: a step towards disease modification. Rev. Esp. Reumatol. 20, Suppl. 1, 221-222.
4. Baici, A., Horler, D., Moser, B., Hofer, H.O., Fehr, K. and Wagenhauser, F.J. (1992) Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulphate. Rheumatol. Int. 12, 81-88.
5. Bassleer, C., Henrotin, Y. and Franchiment, P. (1992) In vitro evaluation of drugs proposed as chondroprotective agents. Int. J. Tissue React. 14, 231-241.
6. Bassleer, C., Reginster, J.Y. and Franchiment, P. (1993) Effects of glucosamine on differentiated human chondrocytes cultivated in clusters. Rev. Esp. Reumatol. 20, Suppl. 1, 96.
7. Bourgeois, P., Charles, G., Dehais, J., Delcambue, B., Kuntz J.-L. and Rozenberg, S. (1998) Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs. chondroitin sulfate 3 x 400 mg/day vs. placebo. Osteoarthritis Cartilage 6, 25-30.
8. Bucsi, L. and Poór, G. (1998) Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 6, 31-36.
9. Burkhardt, D. and Ghosh, P. (1987) Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Sem. Arth. Rheum. 17, Suppl. 1, 3-34.
10. Canapp, S.O., McLaughlin, R.M., Hoskinson, J.J., Roush, J.K. and Butine, M.D. (1999) Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate. Am. J. vet. Res. 60, 1552-1557.
11. Conte, A., De Bernardi, M., Palmieri, L., Lualdi, P., Mautone, G. and Ronca, G. (1991) Metabolic fate of exogenous chondroitin sulphate in man. Arneimittelforsch Drug Res. 41, 768-772.
12. Conte, A., Volpi, N., Palmieri, L., Bahous, I. and Ronca, G. (1995) Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulphate. Drug Res. 45, 918-925.
13. Crolle, G. and D'Est, E. (1980) Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr. Res. med. Opinion 7, 114-119.
14. D'Ambrosio, E., Casa, B., Bompani, R., Scali, G. and Scali, M. (1981) Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeut. 2, 504-508.
15. Dohlman, C.H. (1956) The fate of the sulfate group of chondroitin sulfate after administration to rats. Acta Physiol. Scand. 37, 220-234.
16. Dorna, V.I. and Guerrero, R.C. (1998) Effects of oral and intramuscular use of chondroitin sulfate in induced equine aseptic arthritis. J. equine Vet. Sci. 18, 548-555.
17. Drovanti, A., Bignamini, A.A. and Rovati, A.L. (1980) Therapeutic activity of oral glucosamine sulphate in osteoarthritis: a placebo-controlled double-blind investigation. Clin. Ther. 3, 260-272.
18. Eichler, J. and Nöh, E. (1970) Therapy of deforming arthrosis through the action upon the cartilagenous metabolism. Orthop. Prax. 9, 225-229.
19. Fenton, J.I., Chelebek-Brown, K.A., Peters, T.L. and Canon, J.P. (1999) Glucosamine inhibits interleukin-1β and lipopolysaccharide-induced cartilage degradation in vitro. Vet. Surg. 28, 388.
20. Fenton, J.I., Chelebek-Brown, K.A., Peters, T.L. and Canon, J.P. (2000) Glucosamine HCl induces equine cartilage degradation in explant culture. Osteoarthritis Cartilage 8, 258-265.
21. Ghosh, P., Wells, C., Smith, M. and Hutadilok, N. (1990) Chondroprotection, myth or reality: an experimental approach. Sem. Arthr. Rheum. 19, 3-9.
22. Giocovelli, G. and Rovati, L.C. (1993) Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine. Rev. Esp. Reumatol. 20, Suppl. 1, 96.
23. Hanson, R.R., Smalley, L.R., Huff, G.K., White, S. and Hammad, T.A. (1997) Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Pract. 19, 16-22.
24. Jaeschke, G. and Steinbach, W. (1982) Specific treatment of arthrosis deformans in horses with glucosamine sulfate. Deutsche Tierärztl. Wochenschr. 89, 288-293.
25. Karzel, K. and Domenjoz, R. (1971) Effects of hexosamine derivatives and uronic acid derivatives on glycosaminoglycan metabolism of fibroblast cultures. Pharmacol. 5, 337-345.
26. Konador, A. and Kawiak, J. (1977) Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration. Arch. Immunol. Ther. Expt. (Warsz) 25, 895-903.
27. Lequesne, M. (1993) Guidelines for testing slow acting drugs in osteoarthritis (SADOAs). Rev. Esp. Rheumatol. 20, Suppl. 1, 220-221.
28. Lequesne, M., Brandt, K., Bellamy, N., Moskowitz, R., Menkes, C.J., Pelletier, J.P. and Altman, R. (1994) Guidelines for testing slow acting drugs in osteoarthritis. J. Rheumatol., Suppl. 20, 65-73.
29. Lualdi, P. (1993) Bioavailability of oral chondroitin sulfate. Rheumatol. Int. 13, 39-40.
30. Morveale, P., Manopulo, R., Galati, M., Boccarera, L., Saponati, G. and Bocchi, L. (1996) Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol. 23, 1385-1391.
31. Müller-Fassbender, H., Bach, G.L., Haase, W., Rovati, L.C. and Setnikar, I. (1994) Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2, 61-69.
32. Mund-Hoyn, W.-D. (1980) Medical treatment of spinal arthrosis with glucosamine or phenylbutazone. A controlled study. Therapiewoche 30, 5922-5928.
33. Murnane, T.W. and Belt, W.D. (1972) Uptake of tritiated glucosamine by femur and mandible of 7-day-old and adult mice. J. dent. Res. 51, 652-656.
34. Németh-Csóka, M., Kajtár, M. and Kajtár, J. (1977) The role of sulphation of glycosaminoglycans in their structural and functional characteristics. Connect. Tissue Res. 5, 1-6.
35. Noack, W., Fischer, M., Förster, K.K., Rovati, L.C. and Setnikar, I. (1994) Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 2, 51-59.
36. Palmieri, L., Conte, A., Giovannini, L., Lualdi, P. and Ronca, G. (1990) Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arneimittelforsch Drug Res. 40, 319-323.
37. Paroli, E., Antonilli, L. and Biffoni, M. (1991) A pharmacological approach to glycosaminoglycans. Drug Expt. clin. Res. 17, 9-19.
38. Pujalte, J.M., Llavore, E.P. and Ylescupidez, F.R. (1980) Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis. Curr. Res. med. Opinion 7, 110-114.
39. Raiss, R. (1985) Influence of glucosamine sulfate on experimentally impaired articular cartilage: test of ultrastructural changes in chondrocytes using morphometry. Fortschr. Med. 103, 658-662.
40. Reichelt, A., Fuorster, K.K., Fischer, M., Rovati, L.C. and Setnikar, I. (1994) Efficacy and safety of intramuscular glucosamine sulphate in osteoarthritis of the knee. Arneimittelforsch Drug Res. 44, 74-80.
41. Rodén, L. (1956) Effect of hexosamines on the synthesis of chondroitin sulphuric acid in vitro. Arkh. Kemi. 10, 345-352
42. Ronca, G. and Conte, A. (1993) Metabolic fate of partially depolymerised shark chondroitin sulfate in man. Int. J. clin. Pharmacol. Res. 13, 27-34.
43. Ronca, F., Palmieri, L., Panicucci, P. and Ronca, G. (1998) Anti-inflammatory activity of chondroitin sulphate. Osteoarthritis Cartilage 6, Suppl. A, 14-21.
44. Rovati, L.C., Setnikar, I., Förster, K.K., Reichlert, A. and Noack, W. (1993) Glucosamine sulfate in gonarthrosis: efficacy in placebo controlled studies. Rev. Esp. Reumatol. 20, Suppl. 1, 72.
45. Salyers, A.A. (1979) Energy sources of major intestinal fermentative anaerobes. Am. J. clin. Nutr. 32, 158-163.
46. Salyers, A.A. and O'Brien, M. (1980) Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thelaiotaomicron. J. Bacteriol. 143, 772-780.
47. Serni, V. (1993) Profile of glucosamine sulfate as an example of slow acting drug in osteoarthritis. Rev. Esp. Reumatol. 20, Suppl. 1, 222.
48. 14C] glucosamine to the rat. Pharmacotherap. 3, 538-550.
49. Setnikar, I., Giachetti, C. and Zanolo, G. (1986) Pharmacokinetics of glucosamine in the dog and man. Arzneim Forsch. Drug Res. 36, 729-735.
50. Setnikar, I., Cereda, R., Pacini, M.A. and Revel, L. (1991a) Antireactive properties of glucosamine sulphate. Arzneim Forsch. Drug Res. 41, 157-161.
51. Setnikar, I., Pacini, M.A. and Revel, L. (1991b) Antiarthritic effects of glucosamine sulphate studies on animal models. Arzneim Forsch. Drug Res. 41, 542-545.
52. Setnikar, I., Palumbo, R., Canali, S. and Zonolo, G. (1993) Pharmacokinetics of glucosamine in man. Arzneim Forsch. Drug Res. 43, 1109-1113.
53. Tapadinhas, M.J., Rivera, I.C. and Bignamini, A.A. (1982) Oral glucosamine sulphate in the management of arthrosis: report on a multicentre open investigation in Portugal. Pharmatherap. 3, 157-168.
54. Tesoriere, G., Dores F., Magistro, D. and Castagnetta, L. (1972) Intestinal absorption of glucosamine and N-acetylglucosamine. Experert. 28, 770-771.
55. Todhunter, R.J. (1996) Anatomy and physiology of synovial joints. In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 1-28.
56. Trotter, G.W. (1996) Polysulfated glycosaminoglycan (Adequan) In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 270-280.
57. Uebelhart, D., Thonar, E.J.-M.A., Delmas, P.D., Chantraine, A. and Vignon, E. (1998a) Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 6, Suppl. A, 39-46.
58. Uebelhart, D., Thonar, E.J.-M.A., Zhang, J. and Williams, J.M. (1998b) Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage 6, Suppl. A, 6-13.
59. Vajardul, Y. (1981) Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin. Therap. 3, 336-343.
60. Vaz, A.L. (1982) Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in outpatients. Curr. med. Res. Opinion 8, 145-149.
61. Vidal y Plana, R.R., Bizzarri, D. and Rovati, A.L. (1978) Articular cartilage pharmacology. In vitro studies on glucosamine and nonsteroidal anti-inflammatory drugs. Pharmacol. Res. Comm. 10, 557-569.
62. Vidal y Plana, R.R. and Karzel, K. (1980) Glucosamine: its role in the articular cartilage metabolism 2. Studies on rat and human articular cartilage. Fortschr. Med. 98, 801-806.
63. von Vetter, G. (1969) Lokale therapie der arthrosen mit glukosaminen (Dona 200). Munch. Med. Wochenschr. 3, 1499-1502.
64. White, G.W., Wynn Jones, E., Hamm, J. and Sanders, T. (1994) The efficacy of orally administered sulfated glycosaminoglycan in chemically induced equine synovitis and degenerative joint disease. J. equine vet. Sci. 14, 350-353.
65. Yamanashi, S., Toyoda, H., Furuya, N., Harada, T., Yoshida, K., Toida, T. and Imanari, T. (1991) Metabolic study on chondroitin sulfate in rabbits. Yakagaku Zasshi 3, 73-76.